Relapsing and progressive forms of multiple sclerosis: insights from pathology.
about
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosisNovel Insights and Therapeutics in Multiple SclerosisNutrition facts in multiple sclerosisConcise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegenerationUse of natalizumab in multiple sclerosis: current perspectives.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS PatientsIntrinsic functional plasticity of the sensorimotor network in relapsing-remitting multiple sclerosis: evidence from a centrality analysisSelf-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recoveryLipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationNeurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium.Harnessing the integrated stress response for the treatment of multiple sclerosis.Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot studyDiffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.Evaluating response to disease-modifying therapy in relapsing multiple sclerosis.Inflammatory demyelination alters subcortical visual circuits.Long-term disability and progression in spinal onset multiple sclerosis.Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury.Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination.Reduced Voluntary Activation During Brief and Sustained Contractions of a Hand Muscle in Secondary-Progressive Multiple Sclerosis Patients.The Role of Gut Microbiome and Associated Metabolome in the Regulation of Neuroinflammation in Multiple Sclerosis and Its Implications in Attenuating Chronic Inflammation in Other Inflammatory and Autoimmune Disorders.Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.Bryostatin-1 alleviates experimental multiple sclerosis.Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.
P2860
Q26771635-9F7CAC10-F579-4725-9DA0-19F8A62133D8Q26784619-88BE27E5-D47C-415B-A97C-D2D9C578D18DQ26851247-AAA93BB5-B3AF-4D92-A395-9CDFC8040408Q28649438-D4DF7FBC-5B7B-4610-A26C-96D8C213DFCBQ31114633-E1C20D75-13DC-467F-B8C3-1034AFE793A5Q31139925-0387748F-2427-4C12-9F9A-0D8087DCF385Q33736209-E5CA6D96-92E8-4857-8AD7-97D67A99B5DDQ35673922-D1DA00ED-8902-4895-904D-145F655597CEQ36273819-20D7724B-1381-4BBD-8697-E5ED1410AB11Q36451661-A6FF1996-49BA-4783-A54D-A17B139F7519Q36602139-EFD5D880-22A1-4590-88C1-70ECC663CDF2Q36689566-F33B9F7C-DF94-4829-AFD6-FD9A6A669C72Q37107063-9C29913E-8146-4D4C-9364-9329813AA001Q37281707-0758B23B-35EA-4FB0-8BCD-80AE21CCB8F8Q37589284-DCCD8B48-4863-4BB5-A75E-F56F8D25A922Q37739872-767A3C3C-27F4-4810-BD1B-2F9478770753Q38375605-99050F8C-4354-4276-8335-F07B6BD98D42Q38618188-F78EAF04-8D3E-4E2A-BBEA-1691765FC0F3Q38622652-3E1C6337-A590-4F31-9F7B-4D9FEF534029Q38748464-4F5C38E3-25D2-421E-B48B-71875AD25D69Q38964699-225F68F3-40FA-4B9A-8B6F-3BDC0DEE2B03Q39096824-61A43C16-D5EC-489F-86FB-8EB1D747ED26Q40757131-E3A3167C-D2DD-411D-A5AA-6B14E11B0C78Q47824376-88B81591-DB7D-4EEF-A685-F734CC0C9B3CQ48127262-87FE9EC6-F723-4C67-B8FD-4255CA3BE749Q48658707-C07283EF-D791-4C96-92E3-4A892C22E7F7Q50026432-486EB095-9182-4EA0-84AA-14579637EF54Q52330247-D2BB91D4-B401-4B43-9BEB-C07C51A382B3
P2860
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
@en
type
label
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
@en
prefLabel
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
@en
P2860
P1476
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
@en
P2093
Bruce D Trapp
Ranjan Dutta
P2860
P304
P356
10.1097/WCO.0000000000000094
P577
2014-06-01T00:00:00Z